Benitec Biopharma (BNTC) Research & Development: 2019-2025
Historic Research & Development for Benitec Biopharma (BNTC) over the last 5 years, with Jun 2025 value amounting to $2.9 million.
- Benitec Biopharma's Research & Development fell 18.37% to $2.9 million in Q2 2025 from the same period last year, while for Jun 2025 it was $18.3 million, marking a year-over-year increase of 17.45%. This contributed to the annual value of $18.3 million for FY2025, which is 17.45% up from last year.
- Per Benitec Biopharma's latest filing, its Research & Development stood at $2.9 million for Q2 2025, which was down 55.86% from $6.5 million recorded in Q1 2025.
- In the past 5 years, Benitec Biopharma's Research & Development ranged from a high of $6.5 million in Q1 2025 and a low of $2.2 million during Q1 2022.
- Over the past 3 years, Benitec Biopharma's median Research & Development value was $3.5 million (recorded in 2024), while the average stood at $4.0 million.
- In the last 5 years, Benitec Biopharma's Research & Development spiked by 259.17% in 2021 and then declined by 21.28% in 2022.
- Benitec Biopharma's Research & Development (Quarterly) stood at $3.1 million in 2021, then grew by 19.55% to $3.8 million in 2022, then soared by 35.66% to $5.1 million in 2023, then increased by 5.55% to $5.4 million in 2024, then decreased by 18.37% to $2.9 million in 2025.
- Its Research & Development stands at $2.9 million for Q2 2025, versus $6.5 million for Q1 2025 and $5.4 million for Q4 2024.